(Q61703613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Efficacy of human recombinant DNase in pediatric patients with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

M E Furuya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J L Lezana-Fernández

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J F Hernández-Sierra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J L Ramírez-Figueroa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

Archives of Medical Research

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

30-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

Cystic fibrosis: current survival and population estimates to the year 2000.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

The changing epidemiology of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Pus, deoxyribonucleic acid, and sputum viscosity

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Liquefaction of viscous purulent exudates by deoxyribonuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa]

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Crystallographic refinement and structure of DNase I at 2 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2800%2900258-7

7 January 2021

10.1016/S0188-4409(00)00258-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282177%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference